Characterizing outcomes of ERBB2-amplified biliary tract cancer.

被引：0

作者：

Fox, Daniel Aaron

Haro-Silerio, Jaime

Bhamidipati, Deepak

Meric-Bernstam, Funda

Pant, Shubham

Ross, Jeffrey S.

Hu, Zishuo Ian

Koay, Eugene Jon

Ludmir, Ethan B.

Cao, Hop Sanderson Tran

Tzeng, Ching-Wei D.

Chun, Yun Shin

Vauthey, Jean-Nicolas

Newhook, Timothy E.

Metwalli, Zeyad

Habibollahi, Peiman

Cox, Veronica L.

Kang, Hyunseon

Javle, Milind M.

Lee, Sunyoung S.

机构：

[1] Baylor Coll Med, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX USA

[5] Fdn Med Inc, Cambridge, MA USA

[6] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol, Houston, TX USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Radiat Oncol, Houston, TX USA

[8] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX USA

[9] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Houston, TX USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Abdominal Imaging, Houston, TX USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期

关键词：

261-492-3532-2370-7650-2700; 283-237-2581-144; 298-4768-3691-2722; 261-7540; 613-4678-146; 261-492-9019; 6; 3; 2; 291; 176; 1; 38092-22447; 38092-34303; 38092-18909; 38092-30467; 38092-19994; 38092-32474; 38092-25821; 38092-20248; 38092-20245; 38092-20212; 38092-27371; 38092-33627; 38092-30779; 38092-27507; 38114-38096-7094; 38092-24862; 38092-23140; 38092-22449; 38092-18438; 14; 5; 4;

D O I：

10.1200/JCO.2024.42.3_suppl.492

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：492 / 492

页数：1

共 50 条

[1] AKT signaling in ERBB2-amplified breast cancer
Carmona, F. Javier
Montemurro, Filippo
Kannan, Srinivasaraghavan
Rossi, Valentina
Verma, Chandra
Baselga, Jose
Scaltriti, Maurizio
PHARMACOLOGY & THERAPEUTICS, 2016, 158 : 63 - 70
[2] Genetic alterations in ERBB2-amplified breast carcinomas
Isola, J
Chu, L
DeVries, S
Matsumura, K
Chew, K
Ljung, BM
Waldman, FM
CLINICAL CANCER RESEARCH, 1999, 5 (12) : 4140 - 4145
[3] Genome profiling of ERBB2-amplified breast cancers
Fabrice Sircoulomb
Ismahane Bekhouche
Pascal Finetti
José Adélaïde
Azza Ben Hamida
Julien Bonansea
Stéphane Raynaud
Charlène Innocenti
Emmanuelle Charafe-Jauffret
Carole Tarpin
Farhat Ben Ayed
Patrice Viens
Jocelyne Jacquemier
François Bertucci
Daniel Birnbaum
Max Chaffanet
BMC Cancer, 10
[4] EGFR-dependent matriptase activation in ErbB2-amplified breast cancer
Gaymon, Darius
CANCER RESEARCH, 2018, 78 (13)
[5] Genome profiling of ERBB2-amplified breast cancers
Sircoulomb, Fabrice
Bekhouche, Ismahane
Finetti, Pascal
Adelaide, Jose
Ben Hamida, Azza
Bonansea, Julien
Raynaud, Stephane
Innocenti, Charlene
Charafe-Jauffret, Emmanuelle
Tarpin, Carole
Ben Ayed, Farhat
Viens, Patrice
Jacquemier, Jocelyne
Bertucci, Francois
Birnbaum, Daniel
Chaffanet, Max
BMC CANCER, 2010, 10
[6] MITOCHONDRIAL DNA COPY NUMBER INSTABILITY IN ERBB2-AMPLIFIED BREAST CANCER TUMORS
Ebrahimi, Elmira
Almasi-Hashiani, Amir
Ghaffari, Kimia
Shirkoohi, Reza
EXCLI JOURNAL, 2018, 17 : 149 - 158
[7] TPD52 Represents a Survival Factor in ERBB2-Amplified Breast Cancer Cells
Roslan, Nuruliza
Bieche, Ivan
Bright, Robert K.
Lidereau, Rosette
Chen, Yuyan
Byrne, Jennifer A.
MOLECULAR CARCINOGENESIS, 2014, 53 (10) : 807 - 819
[8] Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers
D Wetterskog
K-K Shiu
I Chong
T Meijer
A Mackay
M Lambros
D Cunningham
J S Reis-Filho
C J Lord
A Ashworth
Oncogene, 2014, 33 : 966 - 976
[9] Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers
Wetterskog, D.
Shiu, K-K
Chong, I.
Meijer, T.
Mackay, A.
Lambros, M.
Cunningham, D.
Reis-Filho, J. S.
Lord, C. J.
Ashworth, A.
ONCOGENE, 2014, 33 (08) : 966 - 976
[10] EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
Sanchez-Vega, Francisco
Hechtman, Jaclyn F.
Castel, Pau
Ku, Geoffrey Y.
Tuvy, Yaelle
Won, Helen
Fong, Christopher J.
Bouvier, Nancy
Nanjangud, Gouri J.
Soong, Joanne
Vakiani, Efsevia
Schattner, Mark
Kelsen, David P.
Lefkowitz, Robert A.
Brown, Karen
Lacouture, Mario E.
Capanu, Marinela
Mattar, Marissa
Qeriqi, Besnik
Cecchi, Fabiola
Tian, Yuan
Hembrough, Todd
Nagy, Rebecca J.
Lanman, Richard B.
Larson, Steven M.
Pandit-Taskar, Neeta
Schoder, Heiko
Iacobuzio-Donahue, Christine A.
Ilson, David H.
Weber, Wolfgang A.
Berger, Michael F.
De Stanchina, Elisa
Taylor, Barry S.
Lewis, Jason S.
Solit, David B.
Carrasquillo, Jorge A.
Scaltriti, Maurizio
Schultz, Nikolaus
Janjigian, Yelena Y.
CANCER DISCOVERY, 2019, 9 (02) : 199 - 209

← 1 2 3 4 5 →